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In Brief
Bademosi et al. use single-molecule
imaging microscopy to understand how
general anesthetics might affect
presynaptic release mechanisms. They
find that a clinically relevant
concentration of propofol targets the
presynaptic release machinery by
specifically restricting syntaxin1A
mobility on the plasma membrane. This
suggests an alternate target process for
these drugs.
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Propofol is the most commonly used general
anesthetic in humans. Our understanding of its
mechanism of action has focused on its capacity
to potentiate inhibitory systems in the brain.
However, it is unknown whether other neural
mechanisms are involved in general anesthesia.
Here, we demonstrate that the synaptic release
machinery is also a target. Using single-particle
tracking photoactivation localization microscopy,
we show that clinically relevant concentrations of
propofol and etomidate restrict syntaxin1A mobility
on the plasma membrane, whereas non-anesthetic
analogs produce the opposite effect and increase
syntaxin1A mobility. Removing the interaction with
the t-SNARE partner SNAP-25 abolishes propofol-
induced syntaxin1A confinement, indicating that
syntaxin1A and SNAP-25 together form an emergent
drug target. Impaired syntaxin1Amobility and exocy-
tosis under propofol are both rescued by co-ex-
pressing a truncated syntaxin1A construct that inter-
acts with SNAP-25. Our results suggest that propofol
interferes with a step in SNARE complex formation,
resulting in non-functional syntaxin1A nanoclusters.INTRODUCTION
General anesthetics abolish consciousness and produce a
behaviorally inert state that is conducive to surgery. Sedation
induced by drugs such as propofol and etomidate is now under-
stood to involve potentiation of GABA(A) receptors in sleep/wake
circuits in the mammalian brain (Brown et al., 2011; Franks,
2008), but it remains unclear what other mechanisms might be
responsible for the complete loss of behavioral responsiveness
seen in all animals exposed to ‘‘surgical’’ concentrations of these
drugs. Whereas general anesthetics target a variety of cellular
functions over a wide range of drug concentrations (Franks,
2006; Franks and Lieb, 1994), there is growing evidence that clin-Ce
This is an open access article under the CC BY-Nically relevant doses of volatile anesthetics (e.g., isoflurane) as
well as intravenous anesthetics (e.g., propofol and etomidate)
also impair SNARE-mediated presynaptic neurotransmitter
release mechanisms (Baumgart et al., 2015; Herring et al.,
2009, 2011; Nagele et al., 2005; van Swinderen and Kottler,
2014; Xie et al., 2013). Genetic mutations in syntaxin1A, a key
membrane-bound SNARE protein required for exocytosis
(S€udhof and Rizo, 2011; S€udhof and Rothman, 2009), have
also been shown to confer resistance to some general anes-
thetics in vitro (Herring et al., 2011; Herring et al., 2009) and in vivo
(Zalucki et al., 2015), suggesting the neurotransmitter release
machinery could also be targeted by these drugs. Recent
investigations using single-molecule imaging have revealed
that changes in synaptic activity are associated with altered
syntaxin1Amobility on the plasmamembrane of live neurosecre-
tory cells andmotor nerve terminals (Bademosi et al., 2017; Gan-
dasi and Barg, 2014; Kasula et al., 2016). Here, we used single-
particle tracking photoactivated localization microscopy
(sptPALM) to track the mobility of individual syntaxin1A mole-
cules in the presence of clinical doses of propofol and etomidate,
the two most common intravenous anesthetics used for per-
forming surgery in human patients.RESULTS
Propofol Impairs Neurotransmission
In our first line of experiments, we confirmed that a clinically
relevant concentration of propofol (3 mM; Sall et al., 2012)
indeed impairs neurotransmitter release in three different live
neural preparations: neurosecretory PC12 cells, cultured rat
cortical neurons, and Drosophila larval motor neurons (Figure 1).
Exposing PC12 cells to propofol (Figure 1A) significantly
decreased evoked release of neuropeptide Y (NPY) (Figure 1B).
We then expressed a genetically encoded reporter of neuro-
transmitter release, synaptophysin-pHluorin (sypHy) (Miesen-
bo¨ck et al., 1998), in rat cortical neuron cultures and measured
exocytosis via unquenching of sypHy at synaptic boutons
following neuronal activation (Figure 1C). Depolarization of neu-
rons produced widespread synaptic release across the cultured
neurons, an effect that was significantly compromised by 3 mM
propofol (Figure 1D). A similar inhibitory effect of propofol onll Reports 22, 427–440, January 9, 2018 ª 2017 The Author(s). 427
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Propofol Decreases Neurotransmitter Release
The effect of propofol on neurotransmitter release was assayed in vitro and
in vivo.
(A and B) Neurosecretory PC12 cells were transfected with NPY-hPLAP and
pretreated for 5 min with either 3 mM of propofol (A) dissolved in DMSO or an
equivalent amount of DMSO to control cells. Cells were treated with either
low-K+ or high-K+ buffers to elicit secretion for 3 min (n = 3 control, n = 3
propofol). (B) The released NPY-hPLAP was measured by luminescence
(Experimental Procedures) and expressed as a percentage of low-K+ release.
3 mM propofol exposure significantly decreased NPY-hPLAP release.
(C) Rat cortical neurons were transfectedwith synaptophysin-pHluorin in order
to visualize KCl-evoked synaptic release events. The curves show average
synaptic intensity traces from neurons perfused with either buffer (control)
or 3 mM propofol solution, normalized against the total releasable pool
(Experimental Procedures).
(D) Propofol perfusion significantly decreased neurotransmitter release.
Number of independent experiments (n) = 6 control, n = 5 propofol; >100
boutons per condition.
(E and F) At the Drosophila larval NMJ, a focal macropatch electrode was used
to record spontaneous and evoked currents (E) generated by an individual type
1b synaptic bouton. Quantal content (F) was calculated from the ratio of
evoked excitatory junctional currents (EJCs) to miniature excitatory junctional
currents (mEJCs) (Experimental Procedures). Average EJC amplitude for
428 Cell Reports 22, 427–440, January 9, 2018neurotransmitter release was detected with electrical stimulation
of the neurons (Figures S1A and S1B). This is consistent with
recent findings for volatile anesthetics in primary hippocampal
neurons (Baumgart et al., 2015). To examine whether this effect
was also evident at naturally formed glutamatergic synapses
in vivo, we performed focal macropatch recordings (Karunanithi
et al., 1999; Karunanithi et al., 2002) from individual boutons at
the neuromuscular junction (NMJ) of larval Drosophila mela-
nogaster flies (Figure 1E). We found that 3 mM propofol signifi-
cantly decreased quantal release from individual boutons
(Figures 1F and S1C–S1E), without affecting the frequency of
non-evoked release events (mEJCs; Figure S1F). This is consis-
tent with recent findings for isoflurane in a similar fly larval prep-
aration (Zalucki et al., 2015). Together, these experiments across
diverse systems indicate that a clinically relevant concentration
of propofol potently disrupts neurotransmitter release and that
this is a presynaptic effect. Importantly, the postsynaptic inhibi-
tory ion channels that form the canonical target mechanism of
propofol (Bali and Akabas, 2004; Franks, 2008) are unlikely to
be involved in these presynaptic preparations. Other target
mechanisms must therefore be present to significantly impair
neurotransmission.
Propofol Restricts Syntaxin1A Mobility on the Cell
Membrane
Like all general anesthetics, propofol is lipophilic and therefore
inserts in the lipid bilayer of neurons (Franks, 2008; Tsuchiya,
2001). Key presynaptic release machinery proteins, such as
syntaxin1A and SNAP-25, are organized in nanoclusters on
the plasma membrane and can dynamically recruit vesicle-
associated membrane protein 2 (VAMP2), leading to exocytosis
at synaptic release sites (Sudhof, 2004; S€udhof and Rizo,
2011). We hypothesized that, by segregating within the plasma
membrane, propofol might compromise the function of mem-
brane-bound SNARE proteins such as syntaxin1A. In order to
assess the behavior of individual syntaxin1A proteins on the
cell membrane, we tagged syntaxin1A with photoconvertible
mEos2 (Figure 2A) and expressed this construct in PC12 cells
(Figure 2Bi). mEos2 photoconversion allows single-molecule
imaging in live cells by total internal reflection fluorescence
(TIRF) microscopy (McKinney et al., 2009). Analysis of single
particles of mEos2-tagged syntaxin1A (Figure 2Bii) allows
quantification of diffusion coefficients of syntaxin1A on the
plasma membrane (Figure 2Biii), as well as defining a super-
resolved intensity map (Figure 2Bii). To quantify syntaxin1A
dynamics (Movie S1), data from multiple trajectories (>3,000
trajectories per cell, 15–30 cells; Figure 2Ci) were combined
to calculate the syntaxin1A-mEos2 mean square displacement
(MSD) and diffusion coefficient frequency distribution (Figures
2D and 2E) in the presence or absence of propofol. As previ-
ously described (Barg et al., 2010; Gandasi and Barg, 2014),
we detected a mobile and immobile population of syntaxin1A
(Figures 2Cii and 2Ciii) indicative of syntaxin1A confinementcontrols, 0.51 ± 0.03; for propofol, 0.39 ± 0.05. Average mEJC amplitude for
controls, 0.16 ± 0.01; for propofol, 0.20 ± 0.01 (n = 12 control, n = 12 propofol).
All results are expressed asmean ±SEM. *p < 0.05, **p < 0.01, and ***p < 0.001
(unpaired Student’s t test). See also Figure S1.
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Figure 2. Propofol Decreases Syntaxin1A Mobility
(A) To carry out single-molecule tracking, syntaxin1A was tagged with a photoconvertible fluorescent protein, mEos2 on the C terminus of the molecule, adjacent
to its transmembrane (TM) domain (left). The extracellular placement of mEos2 allows tracking of syntaxin1A dynamics on the plasma membrane (right).
(B) (i) Low-resolution TIRF image of PC12 cells transfected with syntaxin1A-mEos2 (Sx1A-mEos2). Scale bar, 3mm. Analysis of movies (Movie S1) generated
(sptPALM) intensity (ii) and diffusion maps (iii).
(C) Trajectory (i) maps, color coded in arbitrary units (4,278 trajectories) were also generated. Analysis of syntaxin1A-mEos2 mobility revealed mobile and
immobile populations (ii and iii).
(D)Mean square displacement (MSD) as a function of time for syntaxin1A-mEos2 in control-DMSO and 3 mM-propofol-perfused PC12 cells. Cells were stimulated
with 2 mM BaCl2.
(legend continued on next page)
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within nanoclusters. The presence of 3 mM propofol within a
preparation of stimulated PC12 cells (Heldman et al., 1989;
Kasula et al., 2016) significantly decreased the displacement
of membrane-bound syntaxin1A compared to DMSO controls
(Figure 2D; summed area under the MSD curve [AUC] statistics
shown to the right). DMSO alone had no effect on syntaxin1A
mobility (Figures S2A and S2B). The immobilization effect of
propofol was confirmed by plotting the diffusion coefficient dis-
tribution of syntaxin1A molecules, revealing an increased
immobile fraction and a simultaneous decrease in the mobile
fraction (Figure 2E; change in the mobile/immobile ratio shown
to the right). We saw the same confining effects in unstimulated
PC12 cells (Figures S2C and S2D), indicating that syntaxin1A
mobility is impaired whether or not cells are stimulated. A clin-
ically relevant concentration of another intravenous general
anesthetic, etomidate (Franks, 2006; Giese and Stanley, 1983;
Herring et al., 2011), decreased syntaxin1A mobility in the
same way (Figures S3A–S3E). To confirm that the effect of
propofol on syntaxin1A mobility is also relevant at synapses
in vivo, we expressed a Drosophila mEos2-tagged syntaxin1A
in flies and tracked the dynamics of the protein in larval
NMJ boutons following genetic activation of motor neurons
(Movie S2) (Bademosi et al., 2017). Exposure to 3 mM propofol
significantly decreased syntaxin1A mobility at the fly NMJ in a
similar way (Figures 3A–3C).
Propofol Traps Syntaxin1A before SNARE Complex
Formation
We next investigated whether the mobility of a different SNARE
protein, VAMP2, was also reduced by propofol. Vesicle-bound
VAMP2, or synaptobrevin, interacts with membrane-bound
syntaxin1A and SNAP-25 to form a fusion-ready ternary com-
plex. Most of VAMP2 resides on synaptic vesicles inside the
cell and is thus technically not accessible to our imaging of
events on the plasmamembrane. However, VAMP2 translocates
to the plasmamembrane following vesicle fusion events, where it
remains bound to syntaxin1A and SNAP-25 prior to recycling
(Sudhof, 2004; S€udhof and Rizo, 2011). By tagging VAMP2
with mEos2 (Figure S4A) we were thus able determine whether
VAMP2 mobility on the plasma membrane mirrored syntaxin1A
in the presence of propofol, as this would indicate a post-SNARE
time frame for the effect of propofol. Using our PC12 cell prepa-
ration (Figure S4B), we found that propofol had no effect on
VAMP2-mEos2 mobility (Figure S4C–S4F), showing instead a
tendency for increased mobility. Given that the three SNARE
partners exist as a complex on the membrane only during or
following vesicle fusion (Hayashi et al., 1994; S€udhof and Rizo,
2011; S€udhof and Rothman, 2009), our findings suggest that
the effect of propofol on syntaxin1A mobility occurs prior to for-
mation of the tetrameric complex. This result also shows that
the immobilizing effect of propofol does not generalize to other
molecules associated with the plasma membrane, pointing
instead to a specific effect on pre-SNARE syntaxin1A.(E) The change in mobility was quantified statistically by calculating the area und
mEos2 ranged from 105 to 101 mm2/s. The ratio of the mobile to immobile popu
independent experiments).
Results are expressed as mean ± SEM. ***p < 0.001 (unpaired Student’s t test).
430 Cell Reports 22, 427–440, January 9, 2018Propofol Traps Syntaxin1A in Presynaptic Nanoclusters
Syntaxin1A is organized into nanodomains in vitro and in vivo
(Bademosi et al., 2017; Sieber et al., 2007). As previous studies
have suggested that syntaxin1A mobility within these nanodo-
mains is confined (Bademosi et al., 2017; Bar-On et al., 2012;
Gandasi and Barg, 2014), we next investigated whether the
propofol-mediated decrease in syntaxin1A mobility was associ-
ated with corresponding changes in the size or density of
syntaxin1A nanoclusters. To achieve this, we carried out sin-
gle-molecule localization and cluster parameter measurements
in fixed PC12 cells expressing syntaxin1A-mEos2 (Figure 4A,
left; Experimental Procedures). Cluster maps of syntaxin1A-
mEos2 were generated by calculating Ripley’s K function (Fig-
ure 4A, middle), and the cluster parameters were plotted from
the spatial distribution of the molecules using an autocorrelation
function (Figure 4A, right) (Harper et al., 2016; Sengupta et al.,
2013). Although the cluster radius remained unchanged under
propofol in stimulated PC12 cells (Figure 4B), the density of
syntaxin1A molecules increased significantly (by 3-fold) (Fig-
ure 4C), and the estimated number of molecules per cluster
more than doubled (Figure 4D). Similar effects were observed
in unstimulated cells (Figures 4E–4G), although in this case, the
cluster radius also significantly increased (Figure 4E). The
increase in the density of syntaxin1A molecules probably results
from increased detection of syntaxin1A oligomers rather
than any increased expression levels (Veatch et al., 2012).
Although the number of molecules per cluster appears low
(10) compared to estimates from another study (Sieber
et al., 2007), this may be an underestimate as the co-
expressed syntaxin1A-mEos2 is probably mixed with endoge-
nous syntaxin1A in the same clusters (Zilly et al., 2011). This
suggests that syntaxin1A density may actually be greater than
indicated by our detection methods. To confirm that the lateral
trapping of syntaxin1A within nanoclusters due to propofol is
also relevant at synapses in vivo, we performed the same ana-
lyses on fixedDrosophilaNMJ tissue and found similar clustering
effects (Figures 4H–4K). Interestingly, the estimated number of
(tagged) syntaxin1A molecules per cluster is greater in
Drosophila boutons than PC12 cells (40 versus 10, respec-
tively), which may reflect the fact that these are active synapses.
That propofol increased the density of syntaxin1A molecules in
both suggests interference with a fundamental syntaxin1A
process.
Non-anesthetic Propofol Analogs Increase Syntaxin1A
Mobility on the Membrane
Propofol and etomidate have different molecular structures, yet
both restrict syntaxin1A mobility on the cell membrane, arguing
that this effect is linked to their commoncapacity to act asgeneral
anesthetics. To further investigate this,we tested theeffect of two
propofol analogs, 2,4-diisopropylphenol and 3,5-diisopropyl-
phenol, which closely resemble propofol but are not general an-
esthetics (Krasowski et al., 2001). These compounds differ fromer the MSD curve (AUC). The diffusion coefficient distribution of syntaxin1A-
lations significantly decreased upon propofol perfusion (n = 17–22 cells from 3
See also Figures S2–S4.
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Figure 3. Propofol Decreases Syntaxin1A Mobility In Vivo in Activated Drosophila Larva Motor Nerve Terminals
(A) Slightly oblique illumination was used localize single-molecule mobility of syntaxin1A-mEos2 in transgenic Drosophila melanogaster third-instar larvae
(Movie S2). Low-resolution TIRF image of a type 1b NMJ chain expressing syntaxin1A-mEos2 prior to photoconversion (i). SptPALM average intensity, diffusion
coefficient, and trajectory of syntaxin1A-mEos2 (1,742 trajectories) (ii–iv). Scale bar, 5 mm.
(B) Mean square displacement (MSD) as a function of time of syntaxin1A-mEos2 in control (DMSO) and propofol-perfused Drosophila larvae expressing dTRPA1
at 30C. Change in mobility was quantified statistically from the AUC.
(C) Diffusion coefficient distribution of syntaxin1A-mEos2. The ratio of the mobile to immobile populations significantly decreased upon propofol perfusion.
n = 17–19 NMJ chains from 3 independent experiments.
Results are expressed as mean ± SEM. **p < 0.01 and ***p < 0.001 (unpaired Student’s t test).propofol by the position of a hydroxyl group on the benzene ring
(Figure 5A). Apart from this, the analogs are identical to propofol
in structure and molecular weight, and both are equally lipophilic
(Krasowski et al., 2001; Tsuchiya, 2001). Interestingly, the ana-
logs had the opposite effect to propofol on syntaxin1A mobility
on the cell membrane; both significantly increased syntaxin1A
mobility, in stimulated and unstimulated cells (Figures 5B–5E),
consistent with their lipophilic property on membrane fluidity
(Bahri et al., 2007; Tsuchiya, 2001; Tsuchiya et al., 2010). This
suggests that the observed decrease in syntaxin1A mobility
seen with propofol is linked to its anesthetic quality rather than
its lipophilic nature. This also suggests that propofol specificallyinteracts with syntaxin1A or other SNARE partners. One of the
key syntaxin1A partners immediately prior to SNARE formation
is SNAP-25 (Nagele et al., 2005; Weiser et al., 2013). Therefore,
we next assessed the role of this interaction in mediating the
effect of propofol on syntaxin1A mobility.
Interaction with SNAP-25 Is Necessary for Propofol-
Mediated Trapping
SNAP-25 has been shown to form dimers with syntaxin1A on
the plasmamembrane (Rickman et al., 2004), where both interact
withVAMP2andanumber of accessoryproteins suchasMunc13
and Munc18 to form SNARE complexes (Weninger et al., 2008;Cell Reports 22, 427–440, January 9, 2018 431
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Figure 4. Propofol Traps Syntaxin1A in Nanoclusters In Vitro and In Vivo
Syntaxin1A-mEos2-transfected PC12 cells were fixed with paraformaldehyde before single-molecule localization (SML) imaging and processing.
(A) Left, representative low-resolution TIRF image; middle, the corresponding SML image; and right, the density map of the region of interest generated from
Ripley’s K-function of control-DMSO (top row) and 3 mM-propofol-perfused (bottom row) cells. Scale bar, 5 mm.
(B–D) The cluster radius (B), average density (C), and number of molecules per cluster (D) were obtained from each region of interest by fitting the autocorrelation
values. Three regions of interest were analyzed per cell (n = 28–50 BaCl2–stimulated cells from 3 independent experiments).
(E–G) Cluster radius (E), density (F), and molecules per cluster (G) of localization of syntaxin1A-mEos2 in unstimulated cells (n = 28–49 unstimulated cells from 3
independent experiments).
(legend continued on next page)
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Xiao et al., 2001). If an interaction between SNAP-25 and
syntaxin1A is required for propofol-mediated trapping of
syntaxin1A in nanoclusters, then removing this interaction
should eliminate the effect of propofol on syntaxin1A mobility.
SNAP-25 interacts specifically with the SNARE motif of
syntaxin1A (gold segment in Figure 6A, top) prior to forming a
quadruple helix when both t-SNAREs meet with vesicle-bound
VAMP2 (Weninger et al., 2008; Xiao et al., 2001). We reasoned
that removing the SNARE motif from syntaxin1A might remove
the propofol target and effectively abolish the effect of propofol
on syntaxin1Amobility. To test this,we generatedmEos2-tagged
syntaxin1A deletion constructs inwhich theSNAP-25-interacting
SNAREmotif was entirely or partially removed (Figure 6A, middle
and bottom). Removing all (Sx1AD183–265) or part (Sx1AD204–250)
of the SNARE motif from syntaxin1A abolished the interaction
with SNAP-25 (Figure 6B) as expected (Wu et al., 1999). Prevent-
ing this interaction with SNAP-25 or potentially also syntaxin1A
homophilic interactions (Merklinger et al., 2017; Sieber et al.,
2007) led to an increase in the mobility of Sx1AD204–250-mEos2
compared to wild-type (Figure 6C, gray versus black; Figures
S5A and S5B). Most importantly, the addition of propofol not
only failed to restrict the mobility of Sx1AD204–250-mEos2 but
also increased mobility of the mutant protein even further (Fig-
ure 6C, brown; Figures S6A and S6B), regardless of stimulation
(Figures 6D, S5C, and S5D). Repeating these experiments with
the entire SNAREmotif removed (Sx1AD183–265-mEos2) revealed
similar, but not identical, results (Figures S5E and S5F).
Recent studies have found anoverlap between syntaxin1A and
SNAP-25 clusters (Pertsinidis et al., 2013; Rickman et al., 2004),
supporting the idea that these molecules could interact to form a
joint propofol target. However, in the preceding experiments, we
could not exclude the possibility that proteins other than
SNAP-25might be required for the propofol effect on syntaxin1A
clustering, alsobecause theSNAREmotif of syntaxin1Ahasbeen
shown to drive homophilic interactions of the protein (Sieber
et al., 2007). To confirm that the effect of propofol on syntaxin1A
mobility is indeed SNAP-25 dependent, we co-expressed
syntaxin1A-mEos2 with botulinum neurotoxin E light chain
(BoNT/E-LC), which cleaves SNAP-25 and therefore prevents
formation of SNAP-25-syntaxin1A heterodimers on the plasma
membrane (Hayashi et al., 1994; Rickman et al., 2004). BoNT/
E-LC expression does not significantly alter syntaxin1A mobility
(FiguresS6AandS6B) ashasalsobeenshownpreviously (Kasula
et al., 2016; Ribrault et al., 2011). However, it completely abol-
ished propofol’s immobilizing effect and instead led to increased
syntaxin1A mobility (Figures 6E, 6F, S6C, and S6D). BoNT/E-LC
alsoabolished the clustering effects seenunder propofol (Figures
6G–6J and S6E–S6G). A simple model summarizing our results
so far (Figure 6K) thus proposes that propofol-induced immobili-
zation of syntaxin1A requires interaction with SNAP-25, most
likely prior to SNARE complex assembly.(H) Larvae expressing Sx1A-mEos2 and dTRPA1 were preheated at 30C, disse
before single-molecule localization (SML) of Sx1A-mEos2. Representative low-res
image (middle), and the density map of the region of interest generated from Rip
(I–K) The cluster radius (I), average density (J), and number of molecules per clus
autocorrelation values (n = 31–32 NMJ chains from 3 independent experiments).
Results are expressed as mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 (uA Truncated Syntaxin1A Rescues Exocytosis and
Mobility Effects of Propofol
We have shown that propofol impairs exocytosis (Figure 1) and
propose that this is a consequence of syntaxin1A immobilization
or clustering (Figures 2, 3, 4, 5, and 6). Although we have not yet
established such causality, our model predicts that genetic
manipulations affecting one presynaptic readout (syntaxin1A
mobility) should also affect the other readout (exocytosis). Previ-
ous work has found that co-expression of a truncated isoform of
syntaxin1A (Sx1A227; Figure 7A) rescues the effect of propofol on
exocytosis in PC12 cells (Herring et al., 2011). We therefore
tested whether this genetic manipulation also rescued the effect
of propofol on syntaxin1A mobility. We first confirmed that the
construct indeed rescued evoked exocytosis (Figure 7B). We
added a hemagglutinin (HA) tag at the N terminus of the
truncated construct (Figure 7A, red) to determine whether it
interacted with functional SNARE proteins, including wild-type
syntaxin1A (tagged with mEos2), SNAP-25 (tagged with Myc),
and VAMP2 (tagged with GFP). Co-immunoprecipitation exper-
iments (Experimental Procedures) showed it interacts with
SNAP-25, but not VAMP2 (Figures 7C and 7D). Sx1A227 also
interacts with wild-type syntaxin1A, alongside SNAP-25 (Fig-
ure 7E). This suggests a direct effect on functional syntaxin1A/
SNAP-25 dimers rather than a parallel effect unrelated to SNARE
formation.
We next co-transfected PC12 cells with wild-type syntaxin1A-
mEos2 and Sx1A227 (Figures S7A–S7C) and tracked syntaxin1A-
mEos2mobility in the presence and absence of propofol. Adding
Sx1A227 to the cells had no effect on syntaxin1A mobility in the
absence of propofol (Figures S7D and S7E). However, adding
the truncated construct abolished the effect of propofol on
syntaxin1A mobility in both stimulated and unstimulated cells
(Figures 7F, 7G, S7F, and S7G). This shows that the samemanip-
ulation in PC12 cells (co-expressing Sx1A227) rescues both
exocytosis and syntaxin1A mobility, suggesting that these pre-
synaptic effects of propofol are linked.
DISCUSSION
This study demonstrates that clinical concentrations of a
commonly used GABA-acting general anesthetic, propofol,
also restrict syntaxin1A mobility on the plasma membrane. The
contrast seen with the effect of propofol analogs is particularly
striking, with the non-anesthetic analogs significantly increasing
syntaxin1A mobility instead. Our results indicate that propofol
acts like its non-anesthetic analogs when the interaction be-
tween syntaxin1A and SNAP-25 is lost, suggesting that propofol
targets this interaction to immobilize syntaxin1A. It seems plau-
sible that syntaxin1A confinement to nanoclusters could lead
to impaired neurotransmission, which we also observe under
propofol. However, more work is needed to establish causalitycted, paraformaldehyde-fixed, and processed for active zone immunostaining
olution bruchpilot image of synaptic active zones (left), the corresponding SML
ley’s K-function (right). Scale bar, 5 mm.
ter (K) of Sx1A-mEos2 were obtained from each region of interest by fitting the
npaired Student’s t test).
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reveals a significant increase in syntaxin1A-mEos2 mobility upon perfusion with the analogs.
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Analysis of mobile to immobile ratios revealed a significant increase in syntaxin1A-mEos2 mobility when exposed to the analogs. For each condition, n = 17–21
cells from 3 independent experiments. Results are expressed as mean ± SEM.
(D) MSD of syntaxin1A-mEos2 in unstimulated PC12 cells perfused with 3 mMpropofol and 3 mM non-anesthetic analogs. The AUC reveals a significant increase
in syntaxin1A-mEos2 mobility upon perfusion with the analogs.
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here. How exactly propofol impairs syntaxin1A mobility remains
unclear, although the requirement for SNAP-25 interaction sug-
gests the nanoclusters are composed of syntaxin1A/SNAP-25
heterodimers that have been blocked from proceeding to a sub-
sequent step in SNARE complex formation due to the presence
of the general anesthetic. It is also unclear how a truncated
syntaxin1A protein might preserve this process against the
effects of propofol on syntaxin1A mobility and exocytosis. Our
finding that the truncated syntaxin1A molecule simultaneously
interacts with both SNAP-25 and wild-type syntaxin1A suggests
occupancy of a site that might otherwise be targeted by propo-
fol. In this regard, future experiments with other truncation con-
structs (Metz et al., 2007) employing propofol resistance as a
readout will be helpful toward determining whether the effects
on syntaxin1A mobility and exocytosis are indeed correlated.
In addition to identifying an alternative target process for this
widely used sedative, our findings may provide a more complete
understanding of general anesthesia. Every neuron communi-
cates with other neurons by way of syntaxin1A-mediated neuro-
transmission, which is highly conserved from worms to humans
(Ferro-Novick and Jahn, 1994). Although our experiments were
focused on the intravenous drugs propofol and etomidate, it
will be interesting to see in future studies whether other general
anesthetics have the same effect on syntaxin1A mobility. There
is already considerable evidence that a broader range of general
anesthetics affect synaptic release mechanisms (Herring et al.,
2009, 2011; Xie et al., 2013), and a previous study using nuclear
magnetic resonance found that clinical concentrations of these
drugs interact with syntaxin1A and SNAP-25, but not VAMP2
(Nagele et al., 2005; Weiser et al., 2013), which is consistent
with our conclusion that propofol acts before completed SNARE
formation. One hypothesis consistent with our findings would be
that a general anesthetic target emerges only when syntaxin1A
and SNAP-25 interact on the plasma membrane and that the
association of propofol with this emergent target interferes
with subsequent steps in SNARE formation. This would lead to
a ‘‘traffic jam’’ of syntaxin1A/SNAP-25 heterodimers (or another
pre-SNARE moiety), which would manifest as syntaxin1A
nanoclusters in our analysis. Another explanation for the
decrease in syntaxin1Amobility could be that propofol promotesFigure 6. SNAP-25 Interaction Is Required for Propofol-Mediated Trap
(A) Schematic representation of the protein domains deleted from the syntaxin1
183–265, whereas syntaxin1AD204–250-mEos2 was deleted from 204–250 (Table
(B) Co-immunoprecipitation of SNAP-25 with syntaxin1A-mEos2 and deletion m
and SNAP-25.
(C and D) MSD AUC for syntaxin1A deletion mutants in BaCl2-stimulated and un
For each condition, n = 17–30 cells from 3 independent experiments. Compariso
test (*p < 0.05, **p < 0.01, and ***p < 0.001).
(E) MSD of syntaxin1A-mEos2 in stimulated PC12 cells transfected with BoNT-E/L
perfused with propofol (3 mM) compared with DMSO control cells.
(F) Diffusion coefficient distribution of syntaxin1A-mEos2 in BoNT-E/LC express
revealed a significant increase in syntaxin1A-mEos2 in the presence of BoNT-E/L
expressed as mean ± SEM. Comparisons were performed using one-way ANOV
(G) Density map of syntaxin1A-mEos2 in 3 mM propofol-perfused cells with and
(H–J) The cluster radius (H), average density (I), and number of molecules per cl
condition, n = 32–50 cells from 3 independent experiments. Results are exp
Figures S5 and S6.
(K) Model showing changes in syntaxin1A lateral mobility on the plasma membran
interaction with SNAP-25, as shown by the cleavage of SNAP-25 with BoNT-E/L
436 Cell Reports 22, 427–440, January 9, 2018its recruitment into nonfunctional SNARE complexes that do not
promote vesicle fusion (Bajohrs et al., 2004; Weninger et al.,
2003). Whereas our data suggest interactions in the membrane,
this need not be the only explanation for altered syntaxin1A
mobility. An alternative possibility is that anesthetics might alter
syntaxin1A mobility by more specifically interfering with other
key protein interactions leading to SNARE formation, such as
between syntaxin1A/SNAP-25 and Munc-13 (Metz et al.,
2007), which is a crucial mediator in forming the final tetrameric
complex with VAMP2 (Wang et al., 2017; Yang et al., 2015).
Future experiments testing the effects of mutating candidate
residues in the syntaxin1A SNARE motif should reveal the exact
nature of this propofol-binding target, as has been revealed for
other propofol targets, such as GABAA receptors (Yip et al.,
2013) and TRPA1 channels (Ton et al., 2017).
Like sleep, general anesthesia resembles a reversible switch,
and the search for mechanisms of anesthesia has justifiably
focused on proteins that exert major effects on neuronal excit-
ability, such as inhibitory GABAA receptors, which are indeed
targets of many general anesthetics (Rudolph and Antkowiak,
2004). However, our results and the work of others show that
clinically relevant concentrations of general anesthetics also
compromise neurotransmitter release (Baumgart et al., 2015;
Herring et al., 2009, 2011; Xie et al., 2013; Zalucki et al., 2015),
and our current set of results with intravenous drugs suggests
this may be consequence of effects on syntaxin1A mobility in
the plasma membrane. However, general anesthetics do not
abolish neurotransmission; they only decrease quantal content
(Figure S1C). So how could this be relevant to the behavioral
endpoint that is general anesthesia? With most animal brains
comprising anywhere between millions and trillions of synapses,
it seems plausible that normal brain functions would be compro-
mised if syntaxin1A mobility became globally restricted across a
variety of synapses following exposure to general anesthetics.
While a decrease in quantal content may not significantly impair
some muscular (or spinal cord) functions, it is likely that a
similar effect on central synapses would dramatically change
temporal dynamics in the brain, leading to a loss of functional
connectivity. In support of this view, recent electroenceph-
alogram (EEG) and fMRI studies have shown that functionalping of Syntaxin1A
A tagged with mEos2. Syntaxin1AD183–265-mEos2 has residues deleted from
S1).
utants. Loss of the SNARE motif prevents the interaction between syntaxin1A
stimulated cells normalized against syntaxin1A-mEos2 in DMSO control cells.
ns were performed using one-way ANOVA with Tukey’s multiple comparison
C. The AUC showed significant increase in syntaxin1A-mEos2 mobility in cells
ing cells with and without propofol. Analysis of the mobile to immobile ratios
C and propofol. n = 15–23 cells from 3 independent experiments. Results are
A with Holm-Sidak’s multiple comparison test (*p < 0.05 and ***p < 0.001).
without BoNT-E/LC.
uster (J) of syntaxin1A-mEos2 in PC12 cells expressing BoNT-E/LC. For each
ressed as mean ± SEM. ***p < 0.001 (unpaired Student’s t test). See also
e. Propofol restricts syntaxin1A mobility and this decrease is tightly coupled to
C or by deletion of syntaxin1A SNARE motif. See also Figures S5 and S6.
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Figure 7. Decreased Neurotransmitter Release and Syntaxin1A Mobility Is Rescued by a Truncated Syntaxin1A Protein
(A) Schematic representation of syntaxin1A-mEos2 and the truncated syntaxin1A protein syntaxin1A227 tagged with an HA tag.
(B) NPY-hPLAP was co-transfected into PC12 cells with either an empty vector (PCMV) or syntaxin1A227. Cells were pretreated for 5 min with either 3 mM of
propofol or DMSO. Cells were treated with either low-K+ or high-K+ buffers to elicit secretion for 3 min (n = 3 control, n = 3 propofol). Propofol decreased
NPY-hPLAP release in PCMV transfected cells, but not in syntaxin1A227 transfected cells. The released NPY-hPLAP was expressed as a percentage of low-K+
release. 3 mM propofol exposure significantly decreased NPY-hPLAP release.
(C) Co-immunoprecipitation experiment testing for interaction between the HA-tagged truncated syntaxin1A andMyc-taggedSNAP-25. Red arrowhead points to
successful pull-down of the truncated syntaxin1A protein with SNAP-25.
(D) Co-immunoprecipitation experiment testing interaction between the HA-tagged truncated syntaxin1A protein and GFP-tagged VAMP2.
(E) Co-immunoprecipitation experiment testing for interaction among mEos2-tagged full-length syntaxin1A, HA-tagged truncated syntaxin1A, and Myc-tagged
SNAP-25. Red arrowhead points to successful pull-down of the truncated syntaxin1A protein by the full-length protein via a SNAP-25 interaction (black
arrowhead). 8c3 is an antibody recognizing the wild-type syntaxin1A protein.
(F) MSD of syntaxin1A-mEos2 in BaCl2-stimulated PC12 cells decreased upon propofol perfusion. In PC12 cells co-transfected with syntaxin1A
227, syntaxin1A-
mEos2mobility was unaffected by propofol. The AUC showed significant decrease in syntaxin1A-mEos2mobility in cells perfusedwith propofol (3 mM, red) but no
decrease in syntaxin1A227 transfected cells (orange).
(G) Diffusion coefficient distribution of syntaxin1A-mEos2 in syntaxin1A227-expressing cells upon propofol perfusion. Same experiments as in (F). Analysis of the
mobile to immobile ratios revealed a significant decrease in syntaxin1A-mEos2 in the presence propofol; this decrease was abolished in syntaxin1A227-ex-
pressing cells. n = 19–32 cells from 3 independent experiments. Results are expressed as mean ± SEM. Comparisons were performed using one-way ANOVA
with Tukey’s multiple comparison test (***p < 0.001). See also Figure S7.connectivity throughout the brain is significantly altered in pa-
tients undergoing general anesthesia (Boly et al., 2012; Chennu
et al., 2016; Hudetz, 2012; Lewis et al., 2012). Thus, other manip-ulations that compromise presynaptic communication, including
effects on presynaptic excitability (Baumgart et al., 2015), might
fall into the same category of anesthetic mechanisms as theCell Reports 22, 427–440, January 9, 2018 437
syntaxin1A-mediated effects we describe here, which may be
considered a class of effects that is distinct from GABAergic
sleep-related mechanisms. One possibility, which we have
raised previously (van Swinderen and Kottler, 2014), is that
GABAergic processes (e.g., sedation and loss of consciousness)
are induced at lower drug doses (e.g., <1 mM propofol; Franks
and Lieb, 1994), while the presynaptic processes discussed
here are affected at the slightly higher concentrations required
for surgery. It remains unknown however whether other general
anesthetics target presynaptic mechanisms. A recent study us-
ing hippocampal cultures found that isoflurane inhibits synaptic
vesicle exocytosis through reduced Ca2+ influx rather than
Ca2+-exocytosis coupling (Baumgart et al., 2015). In contrast,
our results suggest that propofol- and etomidate-mediated pre-
synaptic effects might be directly coupled to the exocytosis ma-
chinery. Whether this is a difference between intravenous and
volatile anesthetics is unclear. Nevertheless, a set of distinct pre-
synaptic mechanisms linked to exocytosis might explain why
recovery from general anesthesia appears to involve a different
process than anesthesia induction (Friedman et al., 2010; van
Swinderen and Kottler, 2014); re-establishing functional con-
nectivity after neurotransmission has returned to normal levels
across the brain would likely involve a different process than fall-
ing asleep or waking up. It will be interesting in future research to
use transgenic syntaxin1A animals (Zalucki et al., 2015) to link
the local effects we have found at the presynapse with conse-
quent changes in global readouts, such as whole-brain connec-
tivity and coherence (Cohen et al., 2016).
EXPERIMENTAL PROCEDURES
For a detailed description of the experimental procedures, see Supplemental
Experimental Procedures.
Construction of Genetic Constructs
Rat syntaxin1A-mEos2 and Drosophila syntaxin1A-mEos2 were constructed
as previously described (Bademosi et al., 2017; Kasula et al., 2016).
Syntaxin1A deletions (D183–265 and D204–250) were generated (from rat
syntaxin1A) (Table S1) and truncated syntaxin1A (Sx1A227) from full-length
Drosophila syntaxin1A.
Cell Culture and DNA Transfection
PC12 cells were cultured in DMEM as previously described (Kasula et al.,
2016). Plasmid transfection was carried out with Lipofectamine reagent
(Invitrogen).
Drosophila melanogaster Stocks
Syntaxin1A-mEos2 flies were generated using standard procedures (Bade-
mosi et al., 2017) and housed at room temperature (25C).
sptPALM
For sptPALM of transfected PC12 cells, imaging was carried out on the
Roper Scientific TIRF microscope. In Drosophila larvae, sptPALM was
carried out with oblique illumination using a TIRF-enabled ELYRA PS.1
microscope (Zeiss) as previously described (Bademosi et al., 2017). Data
analysis was carried out using PALM-Tracer, a plugin in Metamorph software
(Molecular Devices).
Single-Molecule Localization Microscopy and Cluster Analysis
PC12 cells or Drosophila third-instar larvae were fixed with 4% paraformalde-
hyde. Single-molecule localization was carried out on an ELYRA PS1 micro-
scope. The datasets were reconstructedwith a pixel size of 10 nm, and regions438 Cell Reports 22, 427–440, January 9, 2018of interest (ROIs) were selected from reconstructed 2D histograms. A custom-
written program (Harper et al., 2016) in MATLAB (TheMathWorks, 2014) quan-
tified the clustering of the proteins using an autocorrelation function. For each
PC12 cell or Drosophila larva NMJ chain, 3 different ROIs were drawn, and the
extracted data were averaged to represent one dataset per cell.
General Anesthetic Concentration
The concentrations of drugs used in this study were determined by spectro-
photometric absorbance readings.
NPY-hPLAP Release Assay
PC12 cells were transfected with NPY fused to the catalytic domain of human
placental alkaline phosphatase (NPY-hPLAP) for 48 hr. NPY-hPLAP released
from cells was measured using the chemiluminescent reporter gene assay
system (Phospha-Light; Applied Biosystems) according to the manufacturer’s
instructions.
Focal Macropatch Recordings from Single Synaptic Boutons
Postsynaptic currents were measured from individual type 1b boutons using
beveled glass electrodes (Karunanithi et al., 1999, 2002).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, one table, and two movies and can be found with this article
online at https://doi.org/10.1016/j.celrep.2017.12.054.
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